Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Overcoming Obstacles in AAV Viral Vector Manufacturing
View All Featured ArticlesHeadline News
Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI
Roche receives CE Mark for compact cobas smart e immunoanalyser
Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Integrity Assurance for Single-Use Systems: End-User Perspective
Presented by Charlotte Masy, Senior Manager in Manufacturing Science and Technology GSK vaccines and Patrick Evrard, Senior Principal Engineer, Single-Use Technologies in Technical Communication and Regulatory Strategy, Pall Corporation
06th October 2021
Effect of Cell Culture Process Change from Fed-batch to Continuous on Productivity and Product Quality
Presented by Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter, Product Line Lead, Cell Culture and Clarification Business at Repligen
25th February 2019
Points to consider when defining a microbial control strategy for individualized ATMPs
Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Lifetime study for JSR Amsphere A3 – protein A resin
Strategy Emerging Markets for Risk Mitigation
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
